Reducing global diabetes burden by implementing solutions and identifying gaps: A Lancet Commission

The Lancet

Volumn 387, Issue 10027, 2016, Pages 1494-1495

  Chan, Juliana C N ^a   Gregg, Edward W ^b   Sargent, Jennifer ^c   Horton, Richard ^c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c THE LANCET   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETES CONTROL; DIABETES MELLITUS; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HEALTH PROGRAM; HUMAN; PATIENT EDUCATION; PRIORITY JOURNAL; SHORT SURVEY; ADVISORY COMMITTEE; CHRONIC DISEASE; COMORBIDITY; COST OF ILLNESS; DIABETES COMPLICATIONS; EVIDENCE BASED MEDICINE; HEALTH; INTERDISCIPLINARY COMMUNICATION; ORGANIZATION; PATIENT CARE;

ADVISORY COMMITTEES; CHRONIC DISEASE; COMORBIDITY; CONGRESSES AS TOPIC; COST OF ILLNESS; DIABETES COMPLICATIONS; DIABETES MELLITUS; EVIDENCE-BASED MEDICINE; GLOBAL HEALTH; HUMANS; INTERDISCIPLINARY COMMUNICATION; PATIENT CARE TEAM;

EID: 84962683988     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)30165-9     Document Type: Note

References (14)

1. International Diabetes Federation IDF diabetes 7th edn. 2015 International Diabetes Federation Brussels http://www.diabetesatlas.org (accessed March 30, 2016).
2. RC Ma, JC Chan Diabetes: incidence of childhood type 1 diabetes: a worrying trend Nat Rev Endocrinol 5 2009 529 530
3. JC Chan, V Malik, W Jia et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology JAMA 301 2009 2129 2140
4. EW Gregg, DE Williams, L Geiss Changes in diabetes-related complications in the United States N Engl J Med 371 2014 286 287
5. SR Seshasai, S Kaptoge, A Thompson et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death N Engl J Med 364 2011 829 841
6. G Li, P Zhang, J Wang et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study Lancet Diabetes Endocrinol 2 2014 474 480
7. DM Nathan, PA Cleary, JY Backlund et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes N Engl J Med 353 2005 2643 2653
8. RR Holman, SK Paul, MA Bethel, DR Matthews, HA Neil 10-year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 359 2008 1577 1589
9. P Gaede, H Lund-Andersen, HH Parving, O Pedersen Effect of a multifactorial intervention on mortality in type 2 diabetes N Engl J Med 358 2008 580 591
10. D Beran, M Ewen, R Laing Constraints and challenges in access to insulin: a global perspective Lancet Diabetes Endocrinol 4 2016 275 285
11. Y Xu, L Wang, J He et al. Prevalence and control of diabetes in Chinese adults JAMA 310 2013 948 959
12. R Miccoli, G Penno, S Del Prato Multidrug treatment of type 2 diabetes: a challenge for compliance Diabetes Care 34 suppl 2 2011 S231 S235
13. AC Tricco, NM Ivers, JM Grimshaw et al. Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis Lancet 379 2012 2252 2261
14. PD Gluckman, MA Hanson, C Cooper, KL Thornburg Effect of in utero and early-life conditions on adult health and disease N Engl J Med 359 2008 61 73